Ajanta Pharma
Drug Manufacturers - Specialty & Generic · AJANTPHARM
Large CapHealthcareHigh Growth
Yogesh M. Agrawal
Managing Director · Visionary
Company DNA
Founder-Centric
About
Ajanta Pharma is a Large Cap company in the Healthcare sector, listed on NSE as AJANTPHARM. With a market cap of ₹37K Cr and revenue of ₹5K Cr, it is currently in the High Growth phase. Known for its Founder-Centric culture and Fast-Follower approach to innovation, the company operates at a Steady-Marathon pace. Significant promoter control with a culture shaped by the Agrawal family's long-term vision for pharmaceutical branding. Its strategic mandate: Building on a strong product base, the firm requires a leader capable of expanding its global footprint and diversifying revenue streams beyond traditional specialties.
FAQ
What kind of company is Ajanta Pharma?
Ajanta Pharma is a Large Cap Healthcare company (AJANTPHARM) in the High Growth phase with a market cap of ₹37K Cr. It is classified as Founder-Centric in culture.
What is Ajanta Pharma's culture and work environment like?
Ajanta Pharma has a Founder-Centric culture with Fast-Follower innovation DNA and a Steady-Marathon pace of execution. Employee brand: Steady Employer. Customer relationship style: B2B-Enterprise. Significant promoter control with a culture shaped by the Agrawal family's long-term vision for pharmaceutical branding.
Who leads Ajanta Pharma?
Ajanta Pharma is led by Yogesh M. Agrawal (Managing Director), a Visionary leader with 29 years of experience.
What are Ajanta Pharma's financials?
Ajanta Pharma reported revenue of ₹5K Cr in FY25 with a 5-year revenue CAGR of 11.8%. Operating margin: 24.6%. Market cap: ₹37K Cr.
Culture & Strategy
CultureFounder-Centric
InnovationFast-Follower
PaceSteady-Marathon
PurposeProfit-Pure
CustomerB2B-Enterprise
EmployeeSteady Employer
BrandTechnical-Expert
LifecycleHigh Growth
Significant promoter control with a culture shaped by the Agrawal family's long-term vision for pharmaceutical branding.
Mandate
Building on a strong product base, the firm requires a leader capable of expanding its global footprint and diversifying revenue streams beyond traditional specialties.
Building on a strong product base, the firm requires a leader capable of expanding its global footprint and diversifying revenue streams beyond traditional specialties.
Financials
Revenue FY25₹5K Cr
PAT FY25₹920 Cr
Rev CAGR 5Y11.8%
OPM24.6%
NPM20.1%
ROE24.3%
ROCE28.1%
P/E37.3
Fwd P/E30.5
P/B8.8
D/E5.7
Mkt Cap₹37K Cr
Promoter66.4%
Institutional21.7%
Similar Culture
Could You Lead Ajanta Pharma?
Take the Genome Benchmark →